Evidence map›Paper›PMID 41579022›Full record

ArticleInternational journal of cancer2026

Th17 cells favor migration and invasiveness of cervical cancer cells under hypoxia in an IGF2BP2-dependent manner.

Selina Gies, Maike Pohlers, Tanja Tänzer, Emmanuel Ampofo, Matthias W Laschke, Moritz Schäfer, Yoo-Jin Kim, Rainer Maria Bohle, Erich-Franz Solomayer, Konrad Wagner and 3 more

Abstract read
In one paragraph

Article in International journal of cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Selina GiesExperimental Gynecological Oncology, Gynecology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
Maike PohlersCenter of Human and Molecular Biology (ZHMB), Institute of Virology, Saarland University, Homburg, Germany.
Tanja TänzerCenter of Human and Molecular Biology (ZHMB), Institute of Virology, Saarland University, Homburg, Germany.
Emmanuel AmpofoInstitute for Clinical and Experimental Surgery, Saarland University, Homburg, Germany.
Matthias W LaschkeInstitute for Clinical and Experimental Surgery, Saarland University, Homburg, Germany.
Moritz SchäferExperimental Gynecological Oncology, Gynecology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
Yoo-Jin KimInstitute of Pathology, Saarland University, Medical Center, Homburg, Germany.
Rainer Maria BohleInstitute of Pathology, Saarland University, Medical Center, Homburg, Germany.
Erich-Franz SolomayerDepartment of Obstetrics and Gynecology, Saarland University, Medical Center, Homburg, Germany.
Konrad WagnerPharmaScienceHub (PSH), Saarbrücken, Germany.
Martin EmptingPharmaScienceHub (PSH), Saarbrücken, Germany.
Alexandra K KiemerPharmaScienceHub (PSH), Saarbrücken, Germany.
Barbara Walch-RückheimExperimental Gynecological Oncology, Gynecology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.ORCID https://orcid.org/0000-0003-3355-8978

Funding

Dr. Rolf M. Schwiete Stiftung 2023-012
6 · The paper itself

Abstract

Hypoxic regions of cervical cancers mediate suppression of the human papillomavirus (HPV) oncoproteins E6 and E7 in an AKT-dependent manner causing oxygen-dependent reversible growth arrest of cancer cells. Furthermore, numbers of T-helper (Th)-17 cells increase during cervical carcinogenesis in cancer tissues, Th17 differentiation is favored by hypoxia and their presence is linked with AKT-dependent therapy resistance, metastases and relapse. As both factors, hypoxia and Th17 cells, are associated with poor prognosis of patients, potential synergistic mechanisms between both are not described so far. In this study, we showed that Th17 cells enhance the expression of hypoxia-related glycolytic enzymes and transporters and functionally favor increased glucose uptake, proliferation and migration of 2D cultures of hypoxic cervical cancer cells as well as invasion of 3D spheroids. As the responsible mediator of increased proliferation, migration and invasion, we identified the RNA-binding protein IGF2BP2 by using small interfering RNAs (siRNAs) for IGF2BP2 as well as small molecule IGF2BP2 inhibitors of the benzamidobenzoic acid class. Consistently, Th17 numbers in cervical cancer biopsies correlated with IGF2BP2 expression associated with lymph node metastases and relapse. Correspondingly, a combination of IGF2BP2 expression and Th17 cell numbers >10/mm

Indexed as

RNA-Binding ProteinsTh17 CellsUterine Cervical NeoplasmsCell HypoxiaCell Line, TumorCell MovementCell ProliferationFemaleHumansNeoplasm InvasivenessIGF2BP2 protein, humanRNA-Binding Proteinscervical cancer progressionhypoxiaIGF2BP2RNA binding protein (RBP)Th17 cells

Identifiers

PMID41579022
PMCPMC13047252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.